Connect with us


RJD Green Inc. (RJDG: OTC Pink Current) | RJD Green, Inc. Updates Progression of Animal Waste Management and 2017 10K Filing



TULSA, OK–(Marketwired – Nov 14, 2017) – RJD Green, Inc. (OTC PINK: RJDG), a three-division holding company focused on the health care services, environmental, and construction/industrial services segments, today announces the Animal Waste Management Division has completed the operating software platform necessary for computerized management of the patented waste to protein process. This allows RJD Green to move forward with capital procurement efforts to build and operate the first plant. Timing of funding efforts is scheduled post audit approval within the acquisition funding package.

The 2017 10K filing has been delayed until this week due to management hours available. Our CEO required a knee-replacement surgery that was unexpected and left only our CFO for corporate management requirements for several weeks until Mr. Brewer’s return to work this week.

“We are most anxious to get back on schedule with our 10K filing and audit completion. Completion of these events allows our Company to move to the next important growth stage,” states RJD Green CFO John Rabbitt.

About RJD Green, Inc.

The Company operates as a holding company with a focus of acquiring and managing assets and companies. RJD Green operates in three divisions: RJD Green Healthcare Services Division, which owns IOSOFT Inc., a company that provides discrete payment technologies, services and software that can be integrated into targeted offerings for healthcare provider networks, hospitals, healthcare payers and individual providers; Earthlinc Environmental Services Division, which provides green environmental services and technologies; and Silex Holdings Division, which is engaged in specialty construction and industrial manufacturing and fills a market niche between the Home Depots and local contractors. Silex offers installed granite/other counter tops, cabinets and related products to the residential builder, commercial contractor, remodel contractor and retail customer.

For more information, visit

Forward-looking Statement:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events of future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluation such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Orexo AB (ORXOY: OTCQX International) | Orexo completes early redemption of existing bond loan





Orexo completes early redemption of existing bond loan

Nov 22, 2017

OTC Disclosure & News Service

Stockholm, Uppsala, Sweden

This release includes additional documents. Select the link(s) below to view.

Press release Orexo completes early redemption of existing bond loan publ. 22.11.2017.pdf

Copyright © 2017 OTC Markets. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Continue Reading


Orexo AB (ORXOY: OTCQX International) | Orexo Completes Early Redemption of Existing Bond Loan



UPPSALA, Sweden, Nov. 22, 2017 /PRNewswire/ — Orexo AB (publ.) (the “Company”) today announces that the Company, in accordance with Orexo’s press release on 31 October 2017, has completed the early total redemption of the existing bond loan (ISIN SE0005932159).

The redemption was made at an amount corresponding to 101 percent of the nominal amount (i.e. SEK 1,010,000 per bond, the nominal amount being SEK 1,000,000) together with accrued but unpaid interest from the preceding interest payment date on November 9 2017 up to, and including, the redemption date on November 22 2017. In conjunction herewith, the bonds are delisted from the corporate bond list of Nasdaq Stockholm.

For further information, please contact:

Orexo AB   (publ.)

Nikolaj Sørensen, President and CEO                         
Tel: +46 (0)18-780-88-00                                              

Henrik Juuel, EVP and CFO
Tel: + 46 (0)18-780-88-00

About Orexo

Orexo develops improved pharmaceuticals based on innovative drug delivery technologies. The focus is primarily on opioid dependence and pain but the aim is to address therapeutic areas where our competence and technologies can create value. The main market today is the US market for the treatment of opioid dependence where the product Zubsolv® is commercialized by Orexo. Other products are commercialized by license partners, including Zubsolv in markets outside of the US. Total net sales for 2016 amounted to SEK 705.9 million and the number of employees was 102. Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) index and is available as ADRs on OTCQX (ORXOY) in the US. The head office, where also research and development is performed, is located in Uppsala, Sweden.

For more information about Orexo please visit, You can also follow Orexo on Twitter, @orexoabpubl, LinkedIn and YouTube. For more information about Zubsolv in the US, see the product and market websites  and

The information was submitted for publication at 8:30 am CET, November 22, 2017

This information was brought to you by Cision,c2396751

The following files are available for download:


View original content:


Copyright © 2017 PR Newswire. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Continue Reading

Recent Posts